Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by O’Neill, G. N.
Right arrow Articles by Brown, R. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by O’Neill, G. N.
Right arrow Articles by Brown, R. H., Jr.
Related Collections
Right arrow Metabolic disease (inherited)
Right arrow All Genetics
Neurology 2001;57:1956-1962
© 2001 American Academy of Neurology


Articles

ABCD1 translation–initiator mutation demonstrates genotype–phenotype correlation for AMN

Gilmore N. O’Neill, MRCPI;, Masashi Aoki, MD and Robert H. Brown, Jr., DPhil, MD

From the Cecil B. Day Laboratory for Neuromuscular Research (Drs. O’Neill, Aoki, and Brown), Massachusetts General Hospital, Boston; and Neurology Department (Dr. Aoki), Tohoku University School of Medicine, Sendai, Japan.

Address correspondence and reprint requests to Dr. Gilmore O’Neill, MGH East, Cecil B. Day Lab., Room #3125, Building 114, 16th Street, Charlestown, MA 02129.

Background:— Inherited mutations of the X-linked adrenoleukodystrophy (X-ALD) gene (ABCD1) cause two neuropathologically distinct disorders: cerebral adrenoleukodystrophy (ALD) and adrenomyeloneuropathy (AMN). The biochemical hallmark of these disorders is a reduction of very long chain fatty acid (VLCFA) ß-oxidation with accumulation of VLCFA esters in neural white matter. More than 300 mutations of the ABCD1 gene have been described. Genotype–phenotype correlation in X-ALD has not been demonstrated; indeed, the two disorders coexist in individual pedigrees and in homozygotic twin pairs.

Methods:— The authors have identified one large kindred with a highly concordant AMN phenotype resembling an X-linked dominant hereditary spastic paraparesis. All obligate female carriers are clinically affected. The ABCD1 gene was examined by direct sequencing of genomic DNA and full-length cDNA. Mutant gene transcription was analyzed by reverse transcriptase PCR. ALD protein (ALDP) expression was tested by Western blotting and indirect immunofluorescence. VLCFA ß-oxidation was examined by in vitro assay.

Results:— The authors have identified a novel deletion of the ABCD1 gene ATG translation initiation codon. The authors have demonstrated that an N-terminal truncated ALDP, missing the first 65 amino acids, is expressed by internal initiation of translation and is correctly trafficked to peroxisomes. They have documented complete penetrance of this mutant in all female carriers. They have also shown that VLCFA ß-oxidation is reduced to 20% of normal in association with this mutant ALDP.

Conclusion:— It appears that initiation of translation at an internal AUG codon generates a truncated ALDP that uniformly leads to an AMN phenotype in this family. Possible models for action of this truncated ALDP and full disease penetrance in heterozygotes are reviewed.




This article has been cited by other articles:


Home page
Hum Mol GenetHome page
M. Asheuer, I. Bieche, I. Laurendeau, A. Moser, B. Hainque, M. Vidaud, and P. Aubourg
Decreased expression of ABCD4 and BG1 genes early in the pathogenesis of X-linked adrenoleukodystrophy
Hum. Mol. Genet., May 15, 2005; 14(10): 1293 - 1303.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by AAN Enterprises, Inc.